Valeri Maria, Zurli Vanessa, Ayala Inmaculada, Colanzi Antonino, Lapazio Lucia, Corda Daniela, Soriani Marco, Pizza Mariagrazia, Rossi Paccani Silvia
Vaccines & Diagnostics s.r.l.-a GSK company- Via Fiorentina 1, Siena, Italy.
Institute of Protein Biochemistry, National Research Council, Via P. Castellino 111, Naples, Italy.
PLoS One. 2015 May 21;10(5):e0127614. doi: 10.1371/journal.pone.0127614. eCollection 2015.
Many pathogenic bacteria utilize ADP-ribosylating toxins to modify and impair essential functions of eukaryotic cells. It has been previously reported that Neisseria meningitidis possesses an ADP-ribosyltransferase enzyme, NarE, retaining the capacity to hydrolyse NAD and to transfer ADP-ribose moiety to arginine residues in target acceptor proteins. Here we show that upon internalization into human epithelial cells, NarE gains access to the cytoplasm and, through its ADP-ribosylating activity, targets host cell proteins. Notably, we observed that these events trigger the disruption of the epithelial monolayer integrity and the activation of the apoptotic pathway. Overall, our findings provide, for the first time, evidence for a biological activity of NarE on host cells, suggesting its possible involvement in Neisseria pathogenesis.
许多致病细菌利用ADP核糖基化毒素来修饰和损害真核细胞的基本功能。此前有报道称,脑膜炎奈瑟菌拥有一种ADP核糖基转移酶NarE,它保留了水解NAD并将ADP核糖部分转移到靶标受体蛋白中精氨酸残基上的能力。在这里,我们表明,NarE内化进入人上皮细胞后,能够进入细胞质,并通过其ADP核糖基化活性靶向宿主细胞蛋白。值得注意的是,我们观察到这些事件会引发上皮单层完整性的破坏和凋亡途径的激活。总体而言,我们的研究结果首次为NarE对宿主细胞的生物学活性提供了证据,表明其可能参与了奈瑟菌的致病过程。